Yes you are right and as soon as we get the efficiency

New Post Public Reply Private Reply Replies (2) Message Board
Cherry67 claydeath1 #5157
423
Yes you are right and as soon as we get the efficiency report I would not doubt one bit that a big pharmaceutical company would want to buy the company and as I have said as long as it in the double digits I'm fine with it

OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 427

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 465

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 387

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 401

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 292

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 472

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 457

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 260

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 296

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 491

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading

Top 5 Most Recently Viewed Articles

Novagold Merger Faces Class Action Investigation

Updated Category News Views 40

Is Novagold's Merger Really Beneficial? Something smells fishy in the world of precious metals, and no, it’s not the gleam of gold we’re talking about. The latest buzz is about Novagold Resources Inc. (NYSE American: NG) and their merger with Donlin Gold LLC. You know the routine: two companies make googly eyes at each other, and before you know it, there’s a merger...

Continue Reading
Global Hemp Based Food Market Insights and Projections

Updated Category News Views 154

Overview of the Global Hemp-Based Food Market The Global Hemp-Based Food Market is on track for significant growth, expected to rise from USD 1.42 billion to USD 4.87 billion. This represents a strong Compound Annual Growth Rate (CAGR) of 13.12% over the forecast period. The surge in this market can be attributed to increasing health awareness and a growing preference for...

Continue Reading
Carnival's Upcoming Earnings: What Investors Should Know

Updated Category News Views 92

Anticipating Carnival's Earnings Forecast Carnival (NYSE: CCL) is gearing up to unveil its quarterly earnings report soon. Investors are keenly observing the upcoming announcement, which is expected to significantly impact market sentiment. Analysts foresee an earnings per share (EPS) of $0.25, a figure that has generated considerable discussion among stakeholders....

Continue Reading
ModuleMD Revolutionizes Allergy Care at AAAAI 2025 Event

Updated Category News Views 131

ModuleMD Revolutionizes Allergy Care at AAAAI 2025 Event ModuleMD made a significant impact at the recent AAAAI event, showcasing 25 years of dedication to allergy practice solutions. As a leader in this industry, their presentation was not just a display; it was an experience that included innovative product launches, interactive demos, and discussions that captivated...

Continue Reading
Billy Markus Clarifies His Role Amid Bitcoin Speculations

Updated Category News Views 248

Billy Markus, a.k.a. Shibetoshi Nakomoto, has struck back at the endless chatter linking him to Bitcoin—like, c’mon people! This dude is solely about Dogecoin. In a flurry of tongue-in-cheek tweets, he laid bare his status: no ties to Bitcoin or any new crypto projects since his last ride with Doge in 2014. His mantra? If it ain't Dogecoin or his old side gig 'Bells,'...

Continue Reading